MALDI-TOF | GenomeWeb

MALDI-TOF

Scientists from the Colorado School of Mines have proposed a method to complement mass spec-based protein profiling. 

While much attention has focused on triple quads, MALDI-TOFs offer advantages in simplicity and throughput that could help them make clinical inroads.

The UK firm is using MALDI-TOF mass spec technology to develop the test as a screening tool for the disorder as early as eight weeks into a pregnancy.

Researchers from the Public Health Agency of Sweden have developed an approach for typing Clostridium difficile isolates based on their patterns of high-molecular weight proteins.

MALDI mass spectrometry continues to make inroads into the microbiology market, with a growing number of researchers and clinicians adopting the technology for microbe identification.

NEW YORK (GenomeWeb News) – Ezose Sciences today said that it has signed an agreement to collaborate with Kyowa Hakko Kirin on glycomics studies using Ezose's GlycanMap platform.

NEW YORK (GenomeWeb News) – Bruker today announced it has licensed intellectual property from the Erasmus Medical Center for the rapid testing of beta-lactamase activity using MALDI-TOF technology.

Glycomics firm Ezose Biosciences said this week it has inked a collaboration agreement with Merck for biomarker discovery research in diabetes.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Bruker and Chungnam National University in South Korea announced today a collaboration to develop MALDI-TOF-based methodologies for the analysis of glycans.

Pages

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.